C9orf50 and gastric cancer: While C9ORF50 has not been functionally characterized, prior studies have linked its aberrant DNA methylation to early diagnostic biomarkers for colorectal and gastric cancers, suggesting its involvement in gastrointestinal cancers [41, 42].